The hepatotoxicity of the isomers of dichlorobenzene: Structure-toxicity relationships and interactions with carbon tetrachloride

Abstract

The three isomers of dichlorobenzene (DCB) exhibit marked differences in hepatotoxicity following intraperitoneal (ip) administration in male F-344 rats. Plasma GPT activity, measured 24 hours post exposure, was elevated to approximately 4080 units/ml following a 1.8 mmol/kg dose of o-DCB. Conversely, n-DCB produced only a moderate elevation (306 units/ml) following a 4.5 mmol/kg dose, while p-DCB produced no elevation in GPT activity at this dose (24 units/ml). Ultra-structurally, o- and m-DCB induced elevations in GPT activity were associated with a centrilobular pattern of hepatic necrosis. The role of cytochrome P-450 mediated bioactivation in DCB-induced hepatotoxicity was demonstrated by elevated GPT activities following an otherwise nontoxic 0.9 mmol/kg dose of either o- or m-DCB in phenobarbital pretreated animals (16770 and 21540 units/ml, respectively). The paraisomer of DCB showed no induction of toxicity with phenobarbital pretreatment. Hepatic glutathione (GSH) concentrations were reduced 0.5, 3 and 5 hours after a 1.8 mmol/kg dose of either o- or m-DCB, a dose which produces hepatotoxicity only for o-DCB. Pretreatment of animals with phorone depleted hepatic GSH to 15% of control levels within two hours; subsequent ip administration of either o- or m-DCB (1.8 mmol/kg) produced approximately equivalent elevations in GPT activity for both isomers (5749 ± 648 and 4732 ± 857 units/ml, respectively). In vitro incubations of o- and m-DCB with GSH and rat liver cytosolic fraction, suggested that GSH may bind m-DCB without prior bioactivation, thereby reducing the hepatotoxicity of this isomer relative to the more toxic ortho isomer. The interactive hepatotoxicity of the dichlorobenzenes with carbon tetrachloride (CCl₄) was also investigated. Concomitant ip injection of CCl₄ (1.0 mmol/kg) and o-DCB (2.7 mmol/kg) produced a marked inhibition of o-DCB hepatotoxicity, as measured by GPT activity (approximately 200 units/ml vs. 7450 units/ml for o-DCB alone). The mechanism of this inhibition of o-DCB hepatotoxicity was shown to be a reduction in the cytochrome P-450 mediated bioactivation of o-DCB, by CCl₄. A similar inhibition of o-DCB hepatotoxicity was seen following administration of CCl₄ as a pretreatment, via the drinking water. Concomitant ip administration of CCl₄ with either m- or p-DCB also produced a reduction in the metabolism of the dichlorobenzene.